Nuveen’s LifeVantage LFVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,828
Closed -$59.7K 3805
2026
Q1
$59.7K Hold
13,828
﹤0.01% 3200
2025
Q4
$85.2K Hold
13,828
﹤0.01% 3220
2025
Q3
$135K Hold
13,828
﹤0.01% 3203
2025
Q2
$181K Buy
+13,828
New +$179K ﹤0.01% 3174
2021
Q2
Sell
-118,572
Closed -$1.11M 3460
2021
Q1
$1.11M Sell
118,572
-874
-0.7% -$8.15K ﹤0.01% 2855
2020
Q4
$1.11M Sell
119,446
-2,915
-2% -$32.7K ﹤0.01% 2763
2020
Q3
$1.48M Buy
122,361
+237
+0.2% +$3.2K ﹤0.01% 2504
2020
Q2
$1.65M Buy
122,124
+19,329
+19% +$268K ﹤0.01% 2417
2020
Q1
$1.06M Buy
102,795
+7,120
+7% +$97.5K ﹤0.01% 2495
2019
Q4
$1.49M Buy
95,675
+45,646
+91% +$671K ﹤0.01% 2538
2019
Q3
$686K Hold
50,029
﹤0.01% 2844
2019
Q2
$649K Buy
+50,029
New +$595K ﹤0.01% 2915

Other funds holding LFVN

Nuveen's LFVN Position: Q2 2026 in Review

Nuveen sold out of LifeVantage (LFVN) in Q2 2026, closing a stake of 13,828 shares — an estimated $59.7K sold.

Nuveen first reported a position in LFVN in Q2 2019 and held it in 12 quarters. The position peaked at $1.65M in Q2 2020. 88 funds tracked by Wall St. Rank hold LFVN as of Q2 2026.

  • Nuveen reported no remaining LifeVantage position as of Q2 2026 after selling out during the quarter.
  • Nuveen sold 13,828 LifeVantage shares in Q2 2026, an estimated $59.7K.
  • Nuveen first reported a position in LifeVantage in Q2 2019 and held it in 12 quarters.
  • Nuveen's LifeVantage position peaked at $1.65M in Q2 2020.
  • 88 funds tracked by Wall St. Rank held LifeVantage as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.